Back to Market Feed

Product Information

GLIPIZIDE-METFORMIN 2.5-500 MG is a generic product labeled by Chartwell RX LLC, priced at $0.2478 per EA under NDC 62135073260. Its NADAC has been published 128 times since Mar 13, 2024.

FDA first approved this application on Jun 23, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLIPIZIDE-METFORMIN 2.5-500 MG

Glipizide and metformin hcl
$0.2478per EA

Strength

2.5; 500 mg/1; mg/1

Manufacturer

Chartwell RX LLC

NDC

62135073260

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078728

FDA Approved

6/23/2010

TE Code

AB

On Market Since

6/29/2010

Pharmacological Classes

Biguanide
Biguanides
Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has been published 128 times since Mar 13, 2024, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2478 per EA
All-time high$0.3512 (Apr 10, 2024)
All-time low$0.2207 (Apr 17, 2024)
52-week high$0.3088
52-week low$0.2223
Median price$0.2419
Average price$0.2584
Largest weekly change-37.1% (Apr 17, 2024)
Weeks tracked128
Tracking sinceMar 13, 2024

Price History

1W

+5.7%

1M

+5.7%

3M

+11.5%

6M

-1.7%

1Y

-12.4%

3Y

N/A

5Y

N/A

All

-17.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Glipizide and metformin hcl market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

METFORMIN HCL 500 MG TABLET
Generic
71093013204•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
71093013205•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
71093013206•ACI Healthcare USA, Inc.
$0.0140
per EA
METFORMIN HCL 500 MG TABLET
Generic
00378718505•Mylan Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
00904716261•Major Pharmaceuticals
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084101•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084105•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084110•Heritage Pharmaceuticals Inc.
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094701•Laurus Labs Limited
$0.0142
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094705•Laurus Labs Limited
$0.0142
per EA

Frequently asked questions

What is the NADAC price of GLIPIZIDE-METFORMIN 2.5-500 MG?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 2.5-500 MG, manufactured by Chartwell RX LLC, is $0.2478 per EA (NDC 62135073260), effective Aug 19, 2026.

How has the price of GLIPIZIDE-METFORMIN 2.5-500 MG changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has declined 17.8%. It has been tracked across 128 weekly CMS publications since Mar 13, 2024.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 2.5-500 MG?

Since Mar 13, 2024, the NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has ranged from a low of $0.2207 (Apr 17, 2024) to a high of $0.3512 (Apr 10, 2024), with a median of $0.2419 per EA.

Are there cheaper alternatives to GLIPIZIDE-METFORMIN 2.5-500 MG?

No other NADAC-published product currently shares the active ingredient and strength of GLIPIZIDE-METFORMIN 2.5-500 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GLIPIZIDE-METFORMIN 2.5-500 MG?

GLIPIZIDE-METFORMIN 2.5-500 MG (NDC 62135073260) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.